These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy. Bowes D; Crook JM; Araujo C; Batchelar D Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473 [TBL] [Abstract][Full Text] [Related]
3. Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion. De Brabandere M; Hoskin P; Haustermans K; Van den Heuvel F; Siebert FA Radiother Oncol; 2012 Aug; 104(2):192-8. PubMed ID: 22857857 [TBL] [Abstract][Full Text] [Related]
4. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy. De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358 [TBL] [Abstract][Full Text] [Related]
5. MRI-based preplanning in low-dose-rate prostate brachytherapy. Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407 [TBL] [Abstract][Full Text] [Related]
6. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Stone NN; Hong S; Lo YC; Howard V; Stock RG Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy. Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887 [TBL] [Abstract][Full Text] [Related]
8. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy. Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002 [TBL] [Abstract][Full Text] [Related]
9. Defining a magnetic resonance scan sequence for permanent seed prostate brachytherapy postimplant assessment. Bowes D; Crook JM; Rajapakshe R; Araujo C; Parker B Brachytherapy; 2013; 12(1):25-9. PubMed ID: 22513105 [TBL] [Abstract][Full Text] [Related]
10. MR and CT image fusion for postimplant analysis in permanent prostate seed implants. Polo A; Cattani F; Vavassori A; Origgi D; Villa G; Marsiglia H; Bellomi M; Tosi G; De Cobelli O; Orecchia R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1572-9. PubMed ID: 15590189 [TBL] [Abstract][Full Text] [Related]
11. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. De Brabandere M; Kirisits C; Peeters R; Haustermans K; Van den Heuvel F Radiother Oncol; 2006 May; 79(2):190-7. PubMed ID: 16707176 [TBL] [Abstract][Full Text] [Related]
12. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants. Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782 [TBL] [Abstract][Full Text] [Related]
13. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry. Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183 [TBL] [Abstract][Full Text] [Related]
14. Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy. Prete JJ; Prestidge BR; Bice WS; Dubois DF; Hotchkiss LA Radiat Oncol Investig; 1998; 6(2):90-6. PubMed ID: 9572685 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis. Al-Qaisieh B; Smith DW; Brearley E; St Clair S; Bownes P Radiother Oncol; 2007 Aug; 84(2):140-7. PubMed ID: 17588696 [TBL] [Abstract][Full Text] [Related]
16. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy. Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606 [TBL] [Abstract][Full Text] [Related]
17. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy. Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859 [TBL] [Abstract][Full Text] [Related]
18. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125. Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031 [TBL] [Abstract][Full Text] [Related]
19. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy. Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148 [TBL] [Abstract][Full Text] [Related]
20. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy? Potters L; Calugaru E; Jassal A; Presser J Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]